EP0731636B1
(en)
*
|
1993-11-30 |
2006-01-11 |
Tanox, Inc. |
Cdn apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
|
US6300482B1
(en)
*
|
1995-01-03 |
2001-10-09 |
Max-Flanck-Gesellschaft Zuer For{Overscore (D)}Erung Der |
MDKI, a novel receptor tyrosine kinase
|
US20060205020A1
(en)
*
|
1995-09-06 |
2006-09-14 |
Icos Corporation |
Cell-cycle checkpoint genes
|
US6136311A
(en)
*
|
1996-05-06 |
2000-10-24 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of cancer
|
US7026445B2
(en)
*
|
1997-02-06 |
2006-04-11 |
Genetics Institute, Llc |
Human SDF-5 protein and compositions
|
US6541212B2
(en)
|
1997-03-10 |
2003-04-01 |
The Regents Of The University Of California |
Methods for detecting prostate stem cell antigen protein
|
US20030171542A1
(en)
*
|
1997-07-03 |
2003-09-11 |
Zymogenetics, Inc. |
Mammalian secretory peptide - 9
|
WO1999058640A2
(en)
*
|
1998-05-11 |
1999-11-18 |
Philadelphia Health And Education Corporation |
Mct-1, a human oncogene
|
US20030055231A1
(en)
*
|
1998-10-28 |
2003-03-20 |
Jian Ni |
12 human secreted proteins
|
ATE283918T1
(en)
*
|
1999-04-26 |
2004-12-15 |
Chugai Pharmaceutical Co Ltd |
TUMOR SUPPRESSOR GENE
|
WO2001044470A1
(en)
*
|
1999-12-16 |
2001-06-21 |
Chugai Seiyaku Kabushiki Kaisha |
Novel human rna helicase, helicain
|
WO2001095205A1
(en)
*
|
1999-12-30 |
2001-12-13 |
Jeffrey Alnwick |
Method and system for ordering items over the internet
|
US7009040B2
(en)
*
|
2003-01-21 |
2006-03-07 |
Arius Research, Inc. |
Cancerous disease modifying antibodies
|
CA2436713A1
(en)
*
|
2000-12-08 |
2002-08-22 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
US20020164703A1
(en)
*
|
2000-12-21 |
2002-11-07 |
Krzysztof Pawlowski |
Card-domain containing polypeptides, encoding nucleic acids, and methods of use
|
US9096663B2
(en)
*
|
2001-02-15 |
2015-08-04 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
|
US7381701B2
(en)
|
2001-02-15 |
2008-06-03 |
The Borad Of Trustees Of The University Of Illinois |
Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
|
IL141647A0
(en)
*
|
2001-02-26 |
2002-03-10 |
Yeda Res & Dev |
Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
|
CA2442993C
(en)
*
|
2001-04-10 |
2011-10-11 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
|
EP1252894A1
(en)
*
|
2001-04-26 |
2002-10-30 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
|
JP2002348254A
(en)
*
|
2001-05-24 |
2002-12-04 |
Japan Science & Technology Corp |
Agent for curing neurogenic tumor
|
US20030109440A1
(en)
*
|
2001-10-03 |
2003-06-12 |
Rigel Pharmaceuticals, Incorporated |
GRB7: novel regulator of lymphocyte signaling
|
US20050026833A1
(en)
*
|
2001-11-08 |
2005-02-03 |
Rabbani Shafaat Ahmed |
PSP-94: use for treatment of hypercalcemia and bone metastasis
|
WO2003046205A2
(en)
*
|
2001-11-28 |
2003-06-05 |
The Burnham Institute |
Methods for identifying modulators of apoptosis
|
US9575070B2
(en)
*
|
2001-12-04 |
2017-02-21 |
Wayne State University |
Neoepitope detection of disease using protein arrays
|
US20050089896A1
(en)
*
|
2003-02-18 |
2005-04-28 |
Roy Frans V. |
Method to control tumor progression and invasiveness
|
US20030186241A1
(en)
*
|
2002-03-20 |
2003-10-02 |
Ken-Shwo Dai |
Human choline/ethanolamine kinase (HCEK)-related gene variant associated with lung cancers
|
AU2003227861A1
(en)
*
|
2002-04-11 |
2003-10-27 |
Oxford Glycosciences (Uk) Ltd |
Protein involved in cancer
|
JP2004057003A
(en)
*
|
2002-06-03 |
2004-02-26 |
Norihiro Chano |
Rb1 gene-induced protein (rb1cc1) and gene
|
AU2003253678A1
(en)
*
|
2002-06-11 |
2003-12-22 |
The General Hospital Corporation |
Identification of inhibitors of mitosis
|
CA2491669A1
(en)
*
|
2002-07-04 |
2004-01-15 |
Oncomab Gmbh |
Neoplasm specific antibodies and uses thereof
|
US7723018B2
(en)
*
|
2002-08-30 |
2010-05-25 |
Rigel Pharmaceuticals, Incorporated |
Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade
|
US20080214437A1
(en)
*
|
2002-09-06 |
2008-09-04 |
Mohapatra Shyam S |
Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases
|
ES2359055T3
(en)
*
|
2002-09-11 |
2011-05-18 |
Genentech, Inc. |
COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TUMOR TREATMENT.
|
DE10248751A1
(en)
*
|
2002-10-18 |
2004-05-06 |
Berdel, Wolfgang E., Prof. Dr.med. |
Dyslocation molecules and their use
|
DE10254601A1
(en)
*
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Gene products differentially expressed in tumors and their use
|
CN1209372C
(en)
*
|
2002-11-27 |
2005-07-06 |
上海市肿瘤研究所 |
Human tumor relative gene CT120 in human 17p 13.3 area and coding protein thereof
|
US20080025989A1
(en)
*
|
2003-02-20 |
2008-01-31 |
Seattle Genetics, Inc. |
Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
|
CA2516455C
(en)
*
|
2003-02-20 |
2012-05-01 |
Seattle Genetics, Inc. |
Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
|
AU2003211683A1
(en)
*
|
2003-02-27 |
2004-09-17 |
Shanghai Genomics, Inc. |
Tumour marker and its use
|
US7488713B2
(en)
|
2004-03-18 |
2009-02-10 |
University Of South Florida |
Cancer treatment using C-type natriuretic peptides
|
DK1641810T4
(en)
*
|
2003-06-24 |
2017-07-03 |
Genomic Health Inc |
Predicting the likelihood of cancer recurrence
|
US8198020B2
(en)
*
|
2003-08-22 |
2012-06-12 |
Potentia Pharmaceuticals, Inc. |
Compositions and methods for enhancing phagocytosis or phagocyte activity
|
CA2559853A1
(en)
*
|
2004-02-17 |
2005-10-13 |
University Of South Florida |
Materials and methods for treatment of inflammatory and cell proliferation disorders
|
US8759317B2
(en)
*
|
2004-03-18 |
2014-06-24 |
University Of South Florida |
Method of treatment of cancer using guanosine 3′, 5′ cyclic monophosphate (cyclic GMP)
|
US20050271670A1
(en)
*
|
2004-04-28 |
2005-12-08 |
Spong Suzanne M |
Treatments for cancer
|
CA2565794A1
(en)
*
|
2004-05-07 |
2005-12-08 |
Yoshikazu Takada |
Endothelial cell apoptosis induced by fibrinogen gamma chain c-terminal fragment
|
AU2005249586B2
(en)
*
|
2004-06-04 |
2010-12-23 |
The Scripps Research Institute |
Compositions and methods for treatment of neovascular diseases
|
WO2006028393A1
(en)
*
|
2004-09-09 |
2006-03-16 |
Auckland Uniservices Limited |
Novel peptides and methods for the treatment of inflammatory disease
|
WO2006050333A2
(en)
*
|
2004-11-02 |
2006-05-11 |
The Regents Of The University Of California |
Methods and compositions for modulating apoptosis
|
KR100664587B1
(en)
*
|
2004-12-22 |
2007-01-04 |
김현기 |
Human cancer suppressor gene protein encoded therein expression vector containing same and cell transformed by said vector
|
WO2006074360A2
(en)
*
|
2005-01-06 |
2006-07-13 |
Eastern Virginia Medical School |
Apolipoprotein a-ii isoform as a biomarker for prostate cancer
|
ES2364670T3
(en)
*
|
2005-02-25 |
2011-09-12 |
Oncotherapy Science, Inc. |
PEPTIDE VACCINES FOR LUNG CANCERS EXPRESSING TTK POLYPEPTIDES.
|
JP5307404B2
(en)
*
|
2005-03-03 |
2013-10-02 |
ケミコム エス.エー. |
Natural ligand of G protein coupled receptor RCC356 and use thereof
|
CN102225200A
(en)
*
|
2005-03-07 |
2011-10-26 |
健泰科生物技术公司 |
Methods and compositions for modulating TWEAK and FN14 activity
|
EP1857817A4
(en)
*
|
2005-03-08 |
2008-08-27 |
Takeda Pharmaceutical |
Screening method
|
US8106002B2
(en)
*
|
2005-04-18 |
2012-01-31 |
Chugai Seiyaku Kabushiki Kaisha |
Anti-cancer agent comprising protein C inhibitor
|
AU2006236225C1
(en)
|
2005-04-19 |
2013-05-02 |
Seagen Inc. |
Humanized anti-CD70 binding agents and uses thereof
|
US20070041944A1
(en)
*
|
2005-05-05 |
2007-02-22 |
The Trustees Of Columbia University In The City Of New York |
Treating tumors by ENH dislocation of ID proteins
|
EP1739092A1
(en)
*
|
2005-06-28 |
2007-01-03 |
I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale |
Peptidic antagonists of class III semaphorins/neuropilins complexes
|
CN100347307C
(en)
*
|
2005-07-25 |
2007-11-07 |
中国人民解放军第四军医大学 |
Recombination chimeric molecule Cb1-Grb2(SH2)-RING eukaryotic expression plasmid and antitumor genetic medicine use
|
WO2007024940A2
(en)
*
|
2005-08-22 |
2007-03-01 |
Dana-Farber Cancer Institute, Inc. |
Mitochondrial localization of muc1
|
WO2007022635A2
(en)
*
|
2005-08-25 |
2007-03-01 |
The University Of Manitoba |
Methods of attenuating prostate tumor growth by insulin-like growth factor binding protein-3 (igfbp-3)
|
DE102005041616B4
(en)
*
|
2005-09-01 |
2011-03-17 |
Johannes-Gutenberg-Universität Mainz |
Melanoma associated MHC class I associated oligopeptides and polynucleotides encoding them and their uses
|
US20070161060A1
(en)
*
|
2005-09-07 |
2007-07-12 |
Anderson Richard A |
Screening method for identifying an agent that modulates PIPKIgamma trafficking of E-cadherin
|
US20090270314A1
(en)
*
|
2005-09-29 |
2009-10-29 |
Tohoku University |
Polypeptide having anti-angiogenic activity
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
US8101173B2
(en)
*
|
2005-12-21 |
2012-01-24 |
Sentoclone International Ab |
Method for treating urinary bladder cancer
|
US7723043B2
(en)
*
|
2006-01-04 |
2010-05-25 |
Picobella, Lp |
Methods for screening for prostate cancer
|
WO2007101222A2
(en)
*
|
2006-02-28 |
2007-09-07 |
Wayne State University |
Cancer treatment
|
GB0607354D0
(en)
*
|
2006-04-12 |
2006-05-24 |
Bioinvent Int Ab |
Agent, Composition And Method
|
WO2007130672A2
(en)
*
|
2006-05-05 |
2007-11-15 |
University Of South Florida |
Urodilatin cancer treatment
|
WO2007133654A2
(en)
*
|
2006-05-10 |
2007-11-22 |
The Trustees Of Columbia University In The City Of New York |
Two pore channels as regulators of proliferation in cancer
|
US9127293B2
(en)
*
|
2006-07-26 |
2015-09-08 |
The University Of Chicago |
Receptor-mediated delivery: compositions and methods
|
US7825092B2
(en)
*
|
2006-08-08 |
2010-11-02 |
University Of South Florida |
Dendroaspis natriuretic peptide for treatment of cancer
|
KR20090064378A
(en)
|
2006-08-10 |
2009-06-18 |
온코세라피 사이언스 가부시키가이샤 |
Genes and polypeptides relating breast cancers
|
JP2010503696A
(en)
*
|
2006-09-13 |
2010-02-04 |
ヌベロ, インコーポレイテッド |
Methods for treating cancer
|
JP5596975B2
(en)
|
2006-10-26 |
2014-10-01 |
ジェネンテック, インコーポレイテッド |
Genetic variation associated with tumors
|
WO2008058380A1
(en)
*
|
2006-11-13 |
2008-05-22 |
Arius Research Inc. |
Cancerous disease modifying antibodies
|
US8420591B2
(en)
*
|
2006-12-08 |
2013-04-16 |
Dana-Farber Cancer Institute, Inc. |
MUC1 and galectin-3
|
US8003761B2
(en)
*
|
2007-01-23 |
2011-08-23 |
Hoffmann-La Roche Inc. |
Cancerous disease modifying antibodies
|
US20080200387A1
(en)
*
|
2007-02-15 |
2008-08-21 |
Hua-Lin Wu |
Anti-angiogenic protein, composition and use thereof
|
US7816082B2
(en)
*
|
2007-03-06 |
2010-10-19 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Methods of identifying pancreatic cancer cells
|
GB0709092D0
(en)
*
|
2007-05-11 |
2007-06-20 |
Borrebaeck Carl |
Diagnosis and method of disease
|
ES2424976T3
(en)
*
|
2007-06-03 |
2013-10-10 |
Oncotx, Inc. |
Cancer-related isoforms of components of transcription factor complexes such as biomarkers and drug targets
|
SI2567707T1
(en)
*
|
2007-07-27 |
2017-01-31 |
Immatics Biotechnologies Gmbh |
Composition of tumour-associated peptides and related anti-cancer vaccine
|
EP2197490A2
(en)
*
|
2007-08-28 |
2010-06-23 |
Biogen Idec MA, Inc. |
Compositions that bind multiple epitopes of igf-1r
|
US20090123439A1
(en)
*
|
2007-11-09 |
2009-05-14 |
The Jackson Laboratory |
Diagnostic and prognosis methods for cancer stem cells
|
EP2222699A1
(en)
*
|
2007-12-17 |
2010-09-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of fzc18-containing collagen 18 polypeptides for the treatment, diagnosis and outcome prediction of diseases
|
WO2009100127A2
(en)
*
|
2008-02-05 |
2009-08-13 |
The Regents Of The University Of California |
Isolated brca1 peptides and method of use
|
US8163551B2
(en)
|
2008-05-02 |
2012-04-24 |
Seattle Genetics, Inc. |
Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
|
US20110052494A1
(en)
*
|
2008-07-21 |
2011-03-03 |
Tweten Rodney K |
H-antigen binding polypeptides and methods of use
|
US8182809B1
(en)
*
|
2008-09-08 |
2012-05-22 |
University Of Washington |
Methods for treating cancer by inhibiting MIC shedding
|
CA2738032A1
(en)
*
|
2008-09-26 |
2010-04-01 |
Proteosys Ag |
Novel antibodies recognizing native annexin a3
|
WO2010048588A2
(en)
*
|
2008-10-23 |
2010-04-29 |
Massachusetts Institute Of Technology |
Directed engagement of activating fc receptors
|
CA2741798A1
(en)
*
|
2008-10-28 |
2010-05-06 |
Shionogi & Co., Ltd. |
Anti-muc1 antibody
|
WO2010073694A1
(en)
*
|
2008-12-25 |
2010-07-01 |
国立大学法人東京大学 |
Diagnosis of treatment of cancer using anti-tm4sf20 antibody
|
WO2010115118A2
(en)
*
|
2009-04-03 |
2010-10-07 |
Antigenics, Inc. |
Methods for preparing and using multichaperone-antigen complexes
|
EP3485912A1
(en)
|
2009-04-08 |
2019-05-22 |
Faulstich, Heinz, Dr. |
Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy
|
SG10201401976YA
(en)
*
|
2009-05-06 |
2014-10-30 |
Biotest Ag |
Uses of immunoconjugates targeting cd138
|
SG176571A1
(en)
*
|
2009-05-19 |
2012-01-30 |
Vivia Biotech Sl |
Methods for providing personalized medicine tests ex vivo for hematological neoplasms
|
EP2436397B1
(en)
|
2009-05-29 |
2017-05-10 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical composition containing antagonist of egf family ligand as component
|
US9241949B2
(en)
*
|
2009-08-14 |
2016-01-26 |
Susann Brady-Kalnay |
Compositions and methods for treating cancer
|
GB0921873D0
(en)
*
|
2009-12-15 |
2010-01-27 |
Cytosystems Ltd |
Assay
|
WO2011094446A1
(en)
|
2010-01-27 |
2011-08-04 |
Neumedicines, Inc |
A method for treating brain cancer using a novel tumor suppressor gene and secreted factor
|
EP2531206B1
(en)
|
2010-02-04 |
2017-05-31 |
Morphotek, Inc. |
Chlorotoxin polypeptides and conjugates and uses thereof
|
CN106957356B
(en)
*
|
2010-05-11 |
2021-05-25 |
弗雷德哈钦森癌症研究中心 |
Chlorotoxin variants, conjugates, and methods of use thereof
|
WO2012008594A1
(en)
*
|
2010-07-15 |
2012-01-19 |
積水メディカル株式会社 |
Method for detecting malignant tumor cells
|
GB201103631D0
(en)
*
|
2011-03-03 |
2011-04-13 |
Univ Leeds |
Identification of candidate therapeutics
|
US10184942B2
(en)
|
2011-03-17 |
2019-01-22 |
University Of South Florida |
Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer
|
CA2834136C
(en)
*
|
2011-04-25 |
2018-04-17 |
Daiichi Sankyo Company, Limited |
Anti-b7-h3 antibody
|
EP2524929A1
(en)
*
|
2011-05-17 |
2012-11-21 |
Sanofi |
Use of anti-CD19 maytansinoid immunoconjugate antibody for the treatment of CD19+ B-cell malignancies syptoms
|
UA112434C2
(en)
|
2011-05-27 |
2016-09-12 |
Ґлаксо Ґруп Лімітед |
ANTIGENCY BINDING SPECIFICALLY Binds to ALL
|
LT3415531T
(en)
*
|
2011-05-27 |
2023-09-25 |
Glaxo Group Limited |
Bcma (cd269/tnfrsf17) - binding proteins
|
US8753640B2
(en)
|
2011-05-31 |
2014-06-17 |
University Of Washington Through Its Center For Commercialization |
MIC-binding antibodies and methods of use thereof
|
EP4011913A1
(en)
|
2011-06-30 |
2022-06-15 |
Chugai Seiyaku Kabushiki Kaisha |
Heterodimerized polypeptide
|
CN102268089A
(en)
*
|
2011-07-05 |
2011-12-07 |
上海交通大学 |
AGR2 (Anterior Gradient-2) blocking antibody and application thereof
|
WO2013062083A1
(en)
|
2011-10-28 |
2013-05-02 |
ファーマロジカルズ・リサーチ プライベート リミテッド |
Cancer stem cell-specific molecule
|
SG11201401699WA
(en)
*
|
2011-11-11 |
2014-09-26 |
Rinat Neuroscience Corp |
Antibodies specific for trop-2 and their uses
|
JP6124261B2
(en)
*
|
2011-11-21 |
2017-05-10 |
国立大学法人 筑波大学 |
Activity regulator, pharmaceutical containing the same, and anti-CD300a antibody
|
EP2788030B1
(en)
|
2011-12-08 |
2018-06-20 |
Biotest AG |
Uses of immunoconjugates targeting cd138
|
ITRM20120060A1
(en)
*
|
2012-02-21 |
2013-08-22 |
Consiglio Nazionale Ricerche |
PEPTIDES ABLE TO RELEASE THE MDM2 / MDM4 HETERODYMER AND THEIR USE IN CANCER TREATMENT.
|
US20150064203A1
(en)
*
|
2012-03-08 |
2015-03-05 |
Japan Science And Technology Agency |
Anticancer agent
|
JP6499079B2
(en)
|
2012-11-13 |
2019-04-10 |
バイオエヌテック アーゲーBioNTech AG |
Agents for treating cancer diseases that express claudin
|
RU2015126650A
(en)
|
2012-12-10 |
2017-01-12 |
Фред Хатчинсон Кэнсер Рисёрч Сентер |
LIPOCALINE PARTNERS
|
AU2013204922B2
(en)
|
2012-12-20 |
2015-05-14 |
Celgene Corporation |
Chimeric antigen receptors
|
EP3446708A1
(en)
*
|
2012-12-24 |
2019-02-27 |
Cell Ideas Pty Ltd. |
Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
|
ES2876009T3
(en)
|
2012-12-27 |
2021-11-11 |
Chugai Pharmaceutical Co Ltd |
Heterodimerized polypeptide
|
CA2907397C
(en)
|
2013-03-15 |
2022-11-22 |
Anthrogenesis Corporation |
Modified t lymphocytes
|
CN105517571A
(en)
*
|
2013-06-24 |
2016-04-20 |
中外制药株式会社 |
Therapeutic agent comprising humanized anti-epiregulin antibody as active ingredient for non-small-cell lung carcinoma excluding adenocarcinoma
|
US9879081B2
(en)
*
|
2013-06-25 |
2018-01-30 |
Samsung Electronics Co., Ltd. |
Protein complex, bispecific antibody including the protein complex, and method of preparation thereof
|
WO2015003114A1
(en)
|
2013-07-05 |
2015-01-08 |
University Of Washington Through Its Center For Commercialization |
Soluble mic neutralizing monoclonal antibody for treating cancer
|
US11559580B1
(en)
|
2013-09-17 |
2023-01-24 |
Blaze Bioscience, Inc. |
Tissue-homing peptide conjugates and methods of use thereof
|
RU2714902C2
(en)
*
|
2013-12-19 |
2020-02-20 |
Новартис Аг |
Chimeric human mesotheliogen antigen receptors and use thereof
|
WO2015109258A1
(en)
*
|
2014-01-16 |
2015-07-23 |
Rowan University |
Modulation of cellular localization of cyclin c
|
US10538591B2
(en)
*
|
2014-03-10 |
2020-01-21 |
The Brigham And Women's Hospital, Inc. |
Anti-fibulin-3 antibodies and uses thereof
|
GB201405845D0
(en)
*
|
2014-04-01 |
2014-05-14 |
Ucl Business Plc |
Signalling system
|
WO2015175965A1
(en)
*
|
2014-05-15 |
2015-11-19 |
The Research Foundation For Suny |
Compositions targeting the interaction domain between p27kip1 and brk and methods of use thereof
|
CN106922148B
(en)
|
2014-07-29 |
2021-10-15 |
瑟勒提斯公司 |
ROR1(NTRKR1) -specific chimeric antigen receptors for cancer immunotherapy
|
US10544201B2
(en)
*
|
2014-07-31 |
2020-01-28 |
Cellectis |
ROR1 specific multi-chain chimeric antigen receptor
|
SG11201700770PA
(en)
*
|
2014-08-19 |
2017-03-30 |
Novartis Ag |
Anti-cd123 chimeric antigen receptor (car) for use in cancer treatment
|
WO2016034666A1
(en)
|
2014-09-04 |
2016-03-10 |
Cellectis |
Trophoblast glycoprotein (5t4, tpbg) specific chimeric antigen receptors for cancer immunotherapy
|
US10577417B2
(en)
*
|
2014-09-17 |
2020-03-03 |
Novartis Ag |
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
|
EP3215522B1
(en)
*
|
2014-11-03 |
2021-12-01 |
Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch Centrum |
T cell receptors directed against bob1 and uses thereof
|
US10047138B1
(en)
*
|
2014-12-03 |
2018-08-14 |
Amgen Inc. |
Fusion protein, cells expressing the fusion protein, and uses thereof
|
IL303247A
(en)
|
2014-12-29 |
2023-07-01 |
Novartis Ag |
Methods of making chimeric antigen receptor-expressing cells
|
CN115029362A
(en)
*
|
2015-02-06 |
2022-09-09 |
新加坡国立大学 |
Nucleic acids, engineered immune cells comprising the same, methods of production and uses thereof
|
US10195272B2
(en)
*
|
2015-03-02 |
2019-02-05 |
The Nemours Foundation |
Adoptive t-cell therapy using FcεRI-based chimeric antigen receptors for treating IgE-mediated allergic diseases
|
US11896614B2
(en)
|
2015-04-17 |
2024-02-13 |
Novartis Ag |
Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells
|
US10752670B2
(en)
|
2015-05-20 |
2020-08-25 |
Cellectis |
Anti-GD3 specific chimeric antigen receptors for cancer immunotherapy
|
WO2017015427A1
(en)
*
|
2015-07-21 |
2017-01-26 |
Novartis Ag |
Methods for improving the efficacy and expansion of immune cells
|
WO2017040945A1
(en)
*
|
2015-09-04 |
2017-03-09 |
Memorial Sloan Kettering Cancer Center |
Immune cell compositions and methods of use
|
US11395826B2
(en)
*
|
2015-11-20 |
2022-07-26 |
Kyushu University, National University Corporation |
Immunoregulatory agent
|
US11648268B2
(en)
|
2015-12-09 |
2023-05-16 |
Memorial Sloan Kettering Cancer Center |
Immune cell compositions and methods of using same
|
JP2019528699A
(en)
|
2016-08-30 |
2019-10-17 |
メモリアル スローン ケタリング キャンサー センター |
Immune cell compositions and methods of use for treating viruses and other infections
|
JP7346291B2
(en)
*
|
2016-09-21 |
2023-09-19 |
アマル セラピューティクス エスエー |
Fusions containing cell-penetrating peptides, multi-epitopes, and TLR peptide agonists for treating cancer
|
US20200016202A1
(en)
*
|
2016-10-07 |
2020-01-16 |
The Brigham And Women's Hospital, Inc. |
Modulation of novel immune checkpoint targets
|
MX2019005833A
(en)
|
2016-11-21 |
2019-10-30 |
Eirion Therapeutics Inc |
Transdermal delivery of large agents.
|
KR20190085528A
(en)
|
2016-11-22 |
2019-07-18 |
싱가포르국립대학교 |
Blocking chimeric antigen receptors and CD7 expression for immunotherapy of T-cell malignancies
|
US11459394B2
(en)
|
2017-02-24 |
2022-10-04 |
Macrogenics, Inc. |
Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereof
|
CN110832075A
(en)
|
2017-03-22 |
2020-02-21 |
诺华股份有限公司 |
Compositions and methods for immunooncology
|
EP3731856A4
(en)
*
|
2017-12-29 |
2021-11-10 |
City of Hope |
Meditope-enabled t cells
|
WO2019200007A1
(en)
*
|
2018-04-10 |
2019-10-17 |
Amgen Inc. |
Chimeric receptors to dll3 and methods of use thereof
|
WO2019212752A1
(en)
*
|
2018-05-03 |
2019-11-07 |
University Of Utah Research Foundation |
Oca-b peptide conjugates and methods of treatment
|
TW202138388A
(en)
|
2019-12-30 |
2021-10-16 |
美商西根公司 |
Methods of treating cancer with nonfucosylated anti-cd70 antibodies
|
JP2023514148A
(en)
*
|
2020-02-05 |
2023-04-05 |
メモリアル スローン ケタリング キャンサー センター |
Chimeric antigen receptor with CD28 mutation and use thereof
|